单细胞分辨率下滤泡辅助性T细胞淋巴瘤的肿瘤异质性与免疫逃逸表型
该研究对滤泡辅助性T细胞淋巴瘤(TFHL)患者的9份淋巴结和16份外周血样本进行单细胞转录组分析,将肿瘤细胞分为5个亚群并发现TFH标志物表达异质性。拷贝数变异累积伴基因突变可能驱动肿瘤细胞向TFH样和增殖表型克隆演化,同时鉴定出肿瘤细胞特异性标志物PLS3,并揭示耗竭CD8+ T细胞增多及免疫抑制微环境形成。
要点
- TFHL肿瘤细胞分为5个亚群,TFH标志物表达异质性显著。
- 拷贝数变异累积伴基因突变可能驱动肿瘤细胞克隆演化。
- 鉴定出肿瘤细胞特异性标志物PLS3,淋巴结和外周血中耗竭CD8+ T细胞显著增多伴寡克隆扩增。
核心结论
- TFHL存在超出既往预期的显著肿瘤细胞异质性和免疫逃逸,可能参与治疗耐药。
研究设计与样本
- 对TFHL患者的9份淋巴结样本和16份外周血样本进行单细胞转录组分析。
主要发现
- 肿瘤细胞分为5个不同亚群,TFH标志物表达水平异质性显著。
- 拷贝数变异和轨迹分析提示拷贝数变异累积伴基因突变可能驱动肿瘤细胞向TFH样和细胞增殖表型克隆演化。
- 鉴定出新的肿瘤细胞特异性标志物PLS3。
- TFHL淋巴结和外周血中耗竭CD8+ T细胞显著增多伴寡克隆扩增,浸润的调节性T细胞、髓系细胞、B细胞和自然杀伤细胞表现出独特的免疫逃逸特征。
- 计算机模拟和空间细胞间相互作用分析揭示肿瘤与免疫细胞间复杂网络驱动免疫抑制微环境形成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T follicular helper (TFH) cell lymphomas (TFHLs) are characterized by TFH-like properties and accompanied by substantial immune-cell infiltration into tumor tissues. Nevertheless, the comprehensive understanding of tumor-cell heterogeneity and immune profiles of TFHL remains elusive. To address this, we conducted single-cell transcriptomic analysis on 9 lymph node (LN) and 16 peripheral blood (PB) samples from TFHL patients. Tumor cells were divided into 5 distinct subclusters, with significant heterogeneity observed in the expression levels of TFH markers. Copy number variation (CNV) and trajectory analyses indicated that the accumulation of CNVs, together with gene mutations, may drive the clonal evolution of tumor cells towards TFH-like and cell proliferation phenotypes. Additionally, we identified a novel tumor-cell-specific marker, PLS3. Notably, we found a significant increase in exhausted CD8+ T cells with oligoclonal expansion in TFHL LNs and PB, along with distinctive immune evasion characteristics exhibited by infiltrating regulatory T, myeloid, B, and natural killer cells. Finally, in-silico and spatial cell-cell interaction analyses revealed complex networking between tumor and immune cells, driving the formation of an immunosuppressive microenvironment. These findings highlight the remarkable tumor-cell heterogeneity and immunoevasion in TFHL beyond previous expectations, suggesting potential roles in treatment resistance.
引用
- Suma S, Suehara Y, Fujisawa M, et al. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Leukemia. 2023. PMID: 38012392. doi:10.1038/s41375-023-02093-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。